M6A RNA modification: focusing on non-small cell lung cancer progression, therapeutic strategies and challenges
N6-methyladenosine (m6A) modification is a pivotal mechanism in RNA epigenetics, with profound implications for lung cancer (LC) biology. This review synthesizes current knowledge on m6A’s multifaceted regulatory networks in non-small cell lung cancer (NSCLC), elucidating its roles in tumor prolifer...
Saved in:
| Main Authors: | Yuyang Yan, Jiarui Yin, Quan Ding, Yan Lu, Shuhua Gou, Xi Xu, Yulin Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1622359/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The therapeutic potential of RNA m(6)A in lung cancer
by: Jingran Yu, et al.
Published: (2024-12-01) -
Biological roles of enhancer RNA m6A modification and its implications in cancer
by: Yangyang Han, et al.
Published: (2025-05-01) -
Epigenetic insights into prostate cancer: exploring histone modifications and their therapeutic implications
by: Bunty Sharma, et al.
Published: (2025-04-01) -
Metabolic reprogramming and therapeutic targeting in non-small cell lung cancer: emerging insights beyond the Warburg effect
by: Hong Cai, et al.
Published: (2025-05-01) -
Chemical reprogramming ameliorates cellular hallmarks of aging and extends lifespan
by: Lucas Schoenfeldt, et al.
Published: (2025-06-01)